Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 7, 2003, Pages 895-902

  Mitra, Amitava ^a   Lin, Senshang ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYANOACRYLATE DERIVATIVE; DEXTRAN 70; LIPID; NANOPARTICLE; PACLITAXEL; PHOSPHATIDYLCHOLINE; POLY(BUTYL 2 CYANOACRYLATE); POLYVINYL ALCOHOL; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FEASIBILITY STUDY; FREEZE DRYING; IN VITRO STUDY; KINETICS; MOLECULAR DYNAMICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; STATISTICAL ANALYSIS; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG CARRIERS; ENBUCRILATE; KINETICS; NANOTECHNOLOGY; PACLITAXEL; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 0042666920     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021341     Document Type: Article

References (33)

1. Aboubakar, M., Puisieux, F., Couvreur, P., Vauthier, C. (1999) Physico-chemical characterization of insulin-loaded poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Int. J. Pharm. 183: 63-66
2. American Cancer Society (2002) Cancer facts and figures, surveillance research. www.cancer.org/downloads/STT/CFF2002.pdf
3. Bissery, M. C., Guenard, D., Guerrite-Voegelein, F., Lavelle, F. (1991) Experimental antitumor activity of taxotere (RP56976, NSC628503) a taxol analogue. Cancer Res. 51: 4845-4852
4. Buckton, G. (1995) Surfactants. In: Buckton, G. (ed.) Interfacial Phenomena in Drug Delivery and Targeting, Vol. 5. Harwood Academic Publishers, London, pp. 157-160
5. Ceruti, M., Crosasso, P., Brusa, P., Arpicco, S., Cattel, L. (2000) Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. J. Control. Release 63: 141-153
6. Couvreur, P., Ronald, M., Speiser, P. (1982) Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them. US Patent 4,329,332.
7. Dosio, F., Arpicco, S., Brusa, P., Stella, B., Cattel, L. (2001) Poly (ethylene glycol)-human serum albumin-paclitaxel conjugates: Preparation, characterization and pharmacokinetics. J. Control. Release 76: 107-117
8. Douglas, S. J., Illum, L., Davis, S. S. (1985) Particle size and size distribution of poly (butyl 2-cyanoacrylate) nanoparticles II. Influence of stabilizers. J. Colloid Interface Sci. 103: 154-163
9. Douglas, S. J., Davis, S. S., Illum, L. (1987) Poly (alkyl 2-cyanoacrylate) (PAC) microspheres as drug carrier systems. In: Illum, L., Davis, S. S. (eds) Polymers in Controlled Drug Delivery. Wright, Bristol, pp. 60-72
10. Duncan, R., Gac-Breton, S., Keane, R., Musila, R., Sat, Y. N., Satchi, R., Searle, F. (2001) Polymer-drug conjugates, PDEPT and PELT: Basic principles for design and transfer from the laboratory to clinic. J. Control. Release 74: 135-146
11. El-Samaligy, M. S., Rohdewald, P. (1982) Triamcinolone diacetate nanoparticles, a sustained release drug delivery system suitable for parenteral administration. Pharm. Acta. Helv. 57: 201-204
12. Feng, S., Huang, G. (2001) Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J. Control. Release 71: 53-69
13. Gorner, T., Gref, R., Michenot, D., Sommer, F., Tran, M. N., Dellacherie, E. (1999) Lidocaine loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J. Control. Release 57: 259-268
14. Govender, T., Riley, T., Ehtezazi, T., Garnett, M. C., Stolnik, S., Illum, L., Davis, S. S. (2000) Defining the drug incorporation properties of PLA-PEG nanoparticles. Int. J. Pharm. 199: 95-110
15. Horwitz, S. B. (1992) Mechanism of action of taxol. Trends Pharmacol. Sci. 13: 134-136
16. Kan, P., Chen, Z. B., Lee, C. J., Chu, I. M. (1999) Development of nonionic surfactant/phospholipid O/W emulsion as a paclitaxel delivery system. J. Control. Release 58: 271-278
17. Kattan, J., Droz, J. P., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P., Brault, P., Vranckx, H., Grognet, J. M., Morge, X. (1992) Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest. New Drugs 10: 191-199
18. Kreuter, J. (1994) Nanoparticles. In: Kreuter, J. (ed.) Colloidal Drug Delivery Systems, Vol. 66. Marcel Dekker Inc, New York, pp. 219-342
19. Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., Alyautdin, R. (2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 10: 317-325
20. Kulkarni, R. K., Porter, H. J., Leonard, F. (1973) Glass transition temperatures of poly (alkyl α-cyanoacrylates). J. Appl. Polymer Sci. 17: 3509-3514
21. Lee, S., Seo, D., Kim, H. W., Jung, S. (2001) Investigation of inclusion complexation of paclitaxel by cyclohenicosakis-(1-2)-(β-D-glucopyranosyl), by cyclic-(1-2)-β-D-glucans (cyclosophoraoses), and by cyclomaltoheptaoses (β-cyclodextrins). Carbohydr. Res. 334: 119-126
22. Liggins, R. T., Burt, H. M. (2001) Paclitaxel loaded poly (L-lactic acid) microspheres: Properties of microspheres made with low molecular weight polymers. Int. J. Pharm. 222: 19-33
23. Miwa, A., Ishibe, A., Nakano, M., Yamahira, T., Itai, S., Jinno, S., Kawahara, H. (1998) Development of novel chitosan derivatives as micellar carriers of taxol. Pharm. Res. 15: 1844-1850
24. Mosqueira, V. C. F., Legrand, P., Pinto-Alphandary, H., Puisieux, F., Barratt, G. (2000) Poly (D, L-lactide) nanocapsules prepared by a solvent displacement process: Influence of the composition on physicochemical and structural properties. J. Pharm. Sci. 89: 614-626
25. Mu, L., Feng, S. S. (2001) Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-coglycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J. Control. Release 76: 239-254
26. Nemati, F., Dubernet, C., Fessi, H., Colin De Verdiere, A., Puisieux, F., Couvreur, P. (1996) Reversion of multidrug resistance using nanoparticles in vitro: Influence of the nature of the polymer. Int. J. Pharm. 138: 237-246
27. Pendri, A., Conover, C. D., Greenwald, R. B. (1998) Antitumor activity of paclitaxel-2′-glycinate conjugated to poly (ethylene glycol): A water-soluble prodrug. Anticancer Drug Des. 13: 387-395
28. Quellec, P., Gref, R., Perrin, L., Dellacherie, E., Sommer, F., Verbavatz, J. M., Alonso, M. J. (1998) Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J. Biomed. Mater. Res. 42: 45-54
29. Singla, A. K., Garg, A., Aggarwal, D. (2002) Paclitaxel and its formulation. Int. J. Pharm. 235: 179-192
30. Vansnick, L., Couvreur, P., Christiaens-Leyh, D., Ronald, M. (1985) Molecular weights of free and drug loaded nanoparticles. Pharm. Res. 2: 36-41
31. Verdun, C., Brasseur, F., Vrancks, H., Couvreur, P., Ronald, M. (1990) Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles. Cancer Chemother. Pharmacol. 26: 13-18
32. Woods, J. (1996) Cyanoacrylates. In: Salamone, J. C. (ed.) Polymeric Materials Encyclopedia, Vol. 2. CRC Press Inc, New York, pp. 1632-1637
33. Zhang, Q., Shen, Z., Nagai, T. (2001) Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int. J. Pharm. 218: 75-80